AI Science Tracker
EN

Affiliation not stated in the indexed abstract reviewed

3 discoveries from 2020 to 2025

Discoveries

Glucobuddy: Detecting Diabetes Risk Using Machine Learning

Source check: Source checked. Not independent scientific confirmation.

Finding: The v1 preprint evaluates supervised models for classifying the PIMA dataset diabetes label from health indicators; a held-out 80/20 evaluation reports performance. This qualifies only as a narrow retrospective dataset classification result, not future-risk prediction, clinical screening, or patient benefit.

Technology: Methods train supervised Logistic Regression, KNN, Gaussian Naive Bayes, Random Forest and SVM models using the dataset outcome label and health features; abstract and Methods differ on algorithm count, so the Results section’s five-model table was followed.

Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Methods train supervised Logistic Regression, KNN, Gaussian Naive Bayes, Random Forest and SVM models using the dataset outcome label and health features; abstract and Methods differ on algorithm count, so the Results section’s five-model table was followed.
Test and result
Held-out table reports Random Forest accuracy 81.0% and ROC-AUC 85.4%; the text elsewhere selects Logistic Regression/Naive Bayes, so no single best-model claim is made.
Limitation / still unknown
PIMA dataset has 768 records, 80/20 stratified split and five-fold training cross-validation. The source notes the narrow demographic dataset, no real-world patient testing and no clinical validation; outcome is existing diabetes status, not prospective risk.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.preprints.org/manuscript/202505.2269

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

An Intelligent System for Prediction of Severity of SARS-Cov-2 Infection and Progression to Critical Illness: Using Machine Learning Models

Source check: Source checked. Not independent scientific confirmation.

Finding: Machine-learning models using clinical and laboratory features predicted SARS-CoV-2 severity and progression to critical illness; the preprint reports cohort-specific performance and predictors.

Technology: Machine-learning models use clinical and laboratory measurements to predict COVID-19 severity and progression to critical illness.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning models use clinical and laboratory measurements to predict COVID-19 severity and progression to critical illness.
Test and result
The preprint reports cohort-specific prediction of severity and critical illness from clinical and laboratory features.
Limitation / still unknown
The evidence is limited to the reported cohorts and predictor evaluation; prospective deployment benefit is not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.21203/rs.3.rs-1074101/v1 · https://europepmc.org/article/PPR/PPR426469 · https://www.researchsquare.com/article/rs-1074101/v1.pdf

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Ultrafast Preliminary Screening of COVID-19 by Machine Learning Analysis of Exhaled NO

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Machine learning analyzes measured exhaled nitric oxide to screen for COVID-19, a specific rapid respiratory-diagnostic application.

Technology: Breath and control data from two Chinese provinces are used to evaluate classification against infection status and comparator measures.

Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Breath and control data from two Chinese provinces are used to evaluate classification against infection status and comparator measures.
Limitation / still unknown
Preliminary screening results require independent prospective confirmation and should not be read as definitive diagnosis.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.researchsquare.com/article/rs-56416/v1.pdf?c=1631870927000

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.